Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial (Q42990184)
Jump to navigation
Jump to search
scientific article published on 15 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial |
scientific article published on 15 March 2013 |
Statements
1 reference
Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial (English)
1 reference
Hadas Dvory-Sobol
1 reference
Kris V Kowdley
1 reference
Eric Lawitz
1 reference
Israel Crespo
1 reference
Tarek Hassanein
1 reference
Michael DeMicco
1 reference
David E Bernstein
1 reference
John M Vierling
1 reference
Stuart C Gordon
1 reference
Jane K Anderson
1 reference
Robert H Hyland
1 reference
Di An
1 reference
Robert G Hindes
1 reference
Efsevia Albanis
1 reference
William T Symonds
1 reference
M Michelle Berrey
1 reference
David R Nelson
1 reference
Ira M Jacobson
1 reference
15 March 2013
1 reference
1 reference
381
1 reference
9883
1 reference
2100-2107
1 reference
Identifiers
1 reference
1 reference